← SynDRA
SAPANISERTIB
SynDRA canonical compound SYN0038223 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | MTOR | PIK3CA | PIK3CD | PIK3CG |
| Mechanism of action | mTOR inhibitor |
All known targets
- MTOR
- PIK3CA
- PIK3CD
- PIK3CG
Mechanisms of action (all sources)
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PIK3CA INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
Cross-references
Synonyms
- INK-128
- MLN-0128
- CB-228
- INK128
- MLN0128
- TAK-228
- INK 128
- INK 128 (MLN0128)
- UNII-JGH0DF1U03
- JGH0DF1U03
- 5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine
- INK-0128
- 3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- C15H15N7O
- 5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- 5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine
- Sapanisertib (USAN/INN)
- Sapanisertib (MLN0128)
- 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
- Sapanisertib [INN]
- 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-
- 1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, 3-(2-AMINO-5-BENZOXAZOLYL)-1-(1-METHYLETHYL)-
- Sapanisertib; INK128
- Sapanisertib [USAN:INN]
- SAPANISERTIB [USAN]
- MLS006011012
- SAPANISERTIB [WHO-DD]
- GTPL7933
- SCHEMBL7902875
- CHEMBL3545097
- CHEBI:91450
- EX-A951
- INK-128/INK128
- BDBM315477
- DTXSID401022538
- HMS3656H12
- HMS3672C21
- INK-128;Sapanisertib;MLN0128
- MFCD22124893
Look up SAPANISERTIB in the interactive SynDRA portal →